Edward Hodgkin

Edward Hodgkin is Chairman of OMass Therapeutics. He is a Partner at Syncona Investment Management Ltd. and was previously a Director of Syncona’s portfolio company, Autolus Therapeutics Ltd. (NASDAQ: AUTL); having served as its first Chief Executive Officer. Prior to Syncona, Ed was Chief Executive Officer of Biotica Technology Ltd. (Cambridge, UK), President & Chief Business Officer of BrainCells Inc. (San Diego, CA) and Vice President, Business Development & Marketing at Tripos (St. Louis, MO). He is also a former chairman of the BioIndustry Association, the UK’s trade body for biotechnology companies. Ed holds an MA and DPhil in Chemistry from the University of Oxford.